NANDORAL ORAL ANABOLIC

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

ETHYLESTRENOL

Available from:

INTERVET AUSTRALIA PTY LIMITED

INN (International Name):

ethyloestrenol(0.5mg/Tb)

Pharmaceutical form:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composition:

ETHYLESTRENOL STEROID-ESTROGEN Active 0.5 mg/Tb

Units in package:

100 Tabs; 500 Tabs

Class:

VM - Veterinary Medicine

Manufactured by:

INTERVET AUSTRALIA

Therapeutic group:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

Therapeutic area:

ENDOCRINE SYSTEM

Therapeutic indications:

ANABOLIC STEROID | ABORTION THREAT | ANDROGENIC PROPERTIES | BONE REPAIR | CATABOLIC COMPLICATIONS | CONVALESCENCE | ERYTHROPOIETIC ACTIVITY | GERIATRIC THERAPY | IMPROVE APPETITE | MALE SEXUAL CHARACTERISITICS | MUSCLE DEVELOPMENT | NON-VIRILISING ANABOLIC | PATHOPHYSIOLOGICAL PROCESS | PROTEIN AND MINERAL ANABOLIC | SKELETAL CONDITIONS | TISSUE BREAKDOWN | TISSUE REPAIR | VIRILISING ANABOLIC

Product summary:

Poison schedule: 4; Withholding period: COLVALESCENCE IMPROVED HEALING RATES O F WOUNDS AND FRACTURES INCREASED APPETI TE WHP: N/A; Host/pest details: CAT: [ANABOLIC STEROID]; DOG: [ANABOLIC STEROID]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [ANABOLIC STEROID]; DOG: [ANABOLIC STEROID]; For use in dogs and cats.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

953 / 5064
090542 I
PMS 328
ZWART
COOL GRAY 9
ORAL ANABOLIC
ETHYLESTRENOL 0.5 MG/TABLET
FOR USE IN DOGS AND CATS
500 TABLETS
NANDORAL
®
090542I
5064.880.2622
Batch No.:/Expiry Date:
READ THE ENCLOSED LEAFLET BEFORE USING THIS
PRODUCT.
DIRECTIONS FOR USE:
Give 0.05 mg/ kg daily (For 10 kg dog give 1 tablet)
DISPOSAL:
Dispose of empty containers by wrapping with paper and
putting in garbage.
STORAGE:
Store below 30°C (Room temperature).
Protect from moisture and light.
Distributed by:
INTERVET AUSTRALIA PTY LIMITED
91-105 HARPIN STREET
BENDIGO EAST VIC 3550
Ph: [phone]
Fax: [phone]
NRA Approval No.: 37217/ 0602
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
C
C
Info
PEST


Verified
ZWART PMS 328 COOL GRAY 9
990 / 5417 090541H
NANDORAL
®
ORAL ANABOLIC
ETHYLESTRENOL 0.5 MG/TABLET
FOR USE IN DOGS AND CATS
100 TABLETS
READ THE ENCLOSED LEAFLET BEFORE USING
THIS PRODUCT.
DIRECTIONS FOR USE:
Give 0.05 mg/kg daily (For 10 kg dog give 1 tablet)
DISPOSAL: Dispose of empty containers by
wrapping with paper and putting in garbage.
STORAGE: Store below 30°C (Room temperature).
Protect from moisture and light.
Distributed by:
INTERVET AUSTRALIA PTY LIMITED
91-105 HARPIN STREET
BENDIGO EAST VIC 3550
PHONE: [phone]
FAX: [phone]
NRA Approval No.: 37217/0602
090541H 5417.880.2621
Batch No./Expiry Date:
C
C
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF THE REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
NANDORAL
®
ORAL ANABOLIC
ETHYLESTRENOL 0.5 mg/ tablet
FOR USE IN DOGS AND CATS
DESCRIPTION:
NANDORAL
®
(Ethylestrenol) is, like NANDROLIN
®
, a product of basic research.
It is a steroid anabolic specifically designed for oral use to
complement
NANDROLIN
®
and LAURABOLIN
®
. The veterinary development of NANDORAL
®
also follows years of research and use in human medicine throughout
the world: it is
accepted as a potent anabolic for use in small animals.
ACTION:
Chemically, estrenol lies bet

Summary of Product characteristics

PRODUCT NAME: NANDORAL® ORAL ANABOLIC
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2009
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Anabolic steroid in tablet form.
TRADE NAME:
NANDORAL
® ORAL ANABOLIC
PRODUCT CODE:
21145-6
RECOMMENDED USE:
For convalescence anti catabolic effect in dogs and cats. It is used
to treat anorexia,
aplastic anaemia, debility, wound/ fracture repair and non specific
dermatoses.
APVMA NO:
37217
CREATION DATE:
November, 2006
THIS VERSION ISSUED:
July, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S20, S45. When using, do not eat or drink. In case of accident or if
you feel unwell, contact a doctor
or Poisons Information Centre immediately (show the label where
possible).
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
White tablets with beveled edges.
ODOUR:
No odour or taste.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
INHALATION:
SHORT TERM EXPOSURE:
Long term inhalation of high amounts of any nuisance dust may overload
lung clearance
mechanism. Available data indicates that this product is not harmful.
However product may be mildly irritating, although
unlikely to cause anything more than mild transient discomfort.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. In addition product is unlikely to cause any discomf